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ABSTRACT (max 300 words)  
Background 
Influenza (“flu”) is a contagious viral infection causing approximately 600 deaths/year in the 
United Kingdom. Annual vaccination is the most effective prevention strategy with a target of 
75% uptake in ‘at-risk’ patient groups. Before 2012, immunisation was conducted in General 
Practice (GP), but uptake was below target. NHS Wales therefore introduced a programme 
allowing community pharmacists to administer the vaccine to certain patient groups.  
Objectives 
This study aimed to evaluate the community pharmacy (CP) flu Vaccination Programme in 
Wales. 
Methods  
A longitudinal study was undertaken by secondary data analysis on data related to all NHS 
funded flu vaccinations administered in CP between 2012-2018 (n=103941). Data were 
analysed using IBM SPSS® and Excel®. Pearson’s correlation and independent sample t-test 
were conducted to compare the number of vaccines administered in CP vs overall numbers and 
those under 65 years and in the ‘at risk’ category in CP and GP respectively. Ethical approval 
was not required.   
Results  
In total, pharmacists administered 103941 vaccinations. Vaccination numbers increased each 
season from 1568 in 2012/13 to 36238 in 2017/18. The main risk group was those aged 65 and 
over (59.9% of vaccinations). The proportion of those vaccinated who were aged <65 years 
and in an ‘at risk’ category was significantly higher in CP than GP (p<0.01). There was a shift 
in balance between vaccinations administered by GPs and CPs in which CPs increased their 
share of all vaccinations in the flu programme from 0.3% in 2012-13 to 5.7% in 2017-18.  A 
strong positive correlation was observed between increasing CP vaccinations and total 
vaccination numbers (R=0.9316, p<0.01).   
Conclusions  
Community pharmacists are providing increasing numbers of flu vaccinations in Wales, 
benefitting patients in all at-risk groups and reinforcing the valuable role of pharmacists at the 
heart of their communities, in terms of public choice and accessibility.  
 
  
INTRODUCTION  
 
Influenza (‘flu’) is a contagious acute respiratory infection caused by the influenza virus, most 
prominent between October and April in the United Kingdom (UK). It can cause sudden fever, 
congestion and severe fatigue.1 These symptoms are usually self-limiting in healthy 
individuals, typically lasting 7-14 days; however, flu can have a severe effect on specific ‘at 
risk’ groups, such as those with diabetes, and the elderly.2 Complications associated with flu 
result in approximately 600 deaths in the UK every year, while it is estimated that annual 
epidemics lead to 290000 to 650000 deaths and up to 5 million cases of severe illness globally.3 
 
The World Health Organization3 (WHO) recommends annual vaccination as the most effective 
prevention method to protect individuals who are most ‘at-risk’ of serious illness or death if 
they contract flu, to reduce transmission of the virus between individuals and ultimately to 
protect vulnerable patients with weakened immune systems.4  Flu vaccination is most 
advantageous if administered before flu begins to circulate (November in the Northern 
Hemisphere) although can be beneficial at any point in a flu season.5  The WHO recommends 
that 75% of patients in ‘at risk’ groups should be vaccinated.6 Patients are currently eligible for 
free NHS flu vaccination in the UK  if they are over the age of 65, pregnant, have certain 
medical conditions, reside in a long stay home or care facility or are a carer or healthcare 
professional.7 
 
Prior to 2012, General Practice (GP) surgeries were the predominant provider of NHS flu 
vaccination and the only provider in primary care. Annual uptake rates have repeatedly fallen 
short of the WHO target.8 In order to improve vaccination uptake, in 2012, Community 
Pharmacies (CPs) in Wales were commissioned to administer NHS vaccinations to eligible 
patients through the introduction of the NHS Seasonal Flu Vaccination Programme (the CP flu 
programme). This was the first national immunisation scheme in the UK in which eligible 
individuals receive their flu vaccine free of charge from a pharmacy, on the NHS via a Patient 
Group Direction (PGD).9,10 Whilst moves to involve pharmacies in the provision of flu 
vaccination have been welcomed by pharmacy representatives11  th y have been controversial, 
with GP leaders asserting that far from increasing uptake, pharmacy vaccination would 
undermine GPs, reduce GP income and leave practices with vaccines that had been “paid for 
but cannot be administered”.12,13  
 
In the UK, prior to the introduction of the CP flu programme, CPs had been providing flu 
vaccinations for many years, vaccinating customers privately.14 Prior to 2015, Wales was the 
only country within the UK to have a national CP influenza programme, although a similar 
programme has since been implemented in England.15 Most research into UK pharmacy 
vaccination programmes has been limited to analyses of the results of single seasons.15,16,17 We 
are unaware of any previous research conducted to longitudinally evaluate any CP flu 
vaccination programmes.   
 
The aim of this study was to evaluate changes in a CP delivered flu vaccination programme, 
over the first six years in Wales (2012-2018). This study is unique in that it utilises data from 
six full flu seasons and includes data on all vaccines administered by pharmacists since the 
inception of the NHS CP flu vaccination service in Wales. 
 
METHODS 
A longitudinal study was undertaken by secondary data analysis of data related to all NHS 
funded flu vaccinations administered in CPs between 4 October 2012 and 31 March 2018 (n = 
103941). 
 
Data on NHS flu vaccinations administered by both pharmacies and GPs, were obtained from 
the NHS Wales Shared Services Partnership. An assumption was made that the number of 
vaccines delivered by other sources, such as private clinics, would consistently be of minimal 
impact on numbers and were therefore not included.  Data were derived from claims submitted 
by CPs for reimbursement (Figure 1). Data were fully anonymised, as such, the study did not 
require ethical approval.  
 
The outcome measures were the number of flu vaccinations administered over time, the 
proportion of vaccines administered by CPs, patient age and gender, eligibility criteria and 
reasons for utilising the service. A vaccination season was defined as vaccinations taking place 
in the period September of one year to April of the next. 
 
Data were coded in Microsoft Excel in order to convert pre-defined text responses (input by 
pharmacist from drop down menus relevant to questions in the consultation record) to numeric 
data that could be descriptively analysed. Data were exported to IBM SPSS® v23; a 10% 
validation check was conducted independently by two researchers for quality assurance of the 
data transfer process. Secondary data analysis was carried out using Microsoft Excel® and IBM 
SPSS® v23 to obtain descriptive statistics. No statistical trend analysis was performed due to 
the limited number of time points available to the researchers. An independent samples t-test 
was undertaken to compare the proportion of vaccines administered to those under 65 and in 
‘at-risk’ groups by GPs and CPs. The relationship between the number of CP vaccinations and 
overall vaccination numbers was carried out using a scatter plot and two tailed Pearson’s 
correlation. 
 
RESULTS 
 
A total of 103941 flu vaccinations were administered in CP in Wales during the six flu seasons 
covered by the study period (see Table 1 for data related to vaccines administered in CPs, by 
GPs and as a whole in Wales).  
 
Numbers and timing of CP NHS flu vaccinations 
 
The total number of patients vaccinated in CPs increased in each flu season; Figure 2 shows 
the cumulative uptake of the NHS CP flu vaccination in Wales by season. Most patients were 
vaccinated in October (66.4%, n = 68972); with the proportion of patients vaccinated in the 
month increasing in each year from 46.0% in 2012/13 to 65.9% in 2017/18. November 
vaccinations accounted for just under a quarter of the total vaccinations (22.5% n = 23491). 
Only around 1 in 10 vaccinations were administered late in the season, between December and 
April (10.5% n = 10936).  
 
Characteristics of service users (Table 2) 
 
Gender data were available for 103846 consultations. The majority of service users were 
female (57.6% n = 59801).  
 
Age data were available for 103880 consultations. The median age of individuals vaccinated 
was 68 years (IQR 54-74).  The median age of service users increased after 2012/13 and 
remained stable in each of the subsequent flu seasons. Over half of service users were aged 65 
or over and there was an increase in the proportion of patients aged 65 or over vaccinated over 
the study period (from 30.0% to 59.9%) as a whole.  Whilst there was a corresponding decrease 
in the proportion of those vaccinated who met eligibility criteria for those under 65 years, the 
overall increase in vaccination numbers in each year meant the number of individuals 
vaccinated in CPs from the largest ‘at-risk’ groups, increased in absolute terms in each year of 
the service.   
 
The proportion of those vaccinated who were aged <65 years and in a clinical ‘at-risk’ group 
was significantly higher in CP than GP (Table 1) (mean proportion of vaccinations which were 
<65 years and in a clinical ‘at-risk’ group: 47.5% v 28.6%; difference 19.0%; 95% CI 8.6 to 
29.3; p<0.01). 
 
Reason for accessing flu vaccination from a CP 
 
Service users were asked whether at the time of vaccination, they had been offered an 
appointment for flu vaccination by their GP practice. Data were available for all vaccinations 
undertaken by pharmacies from 2013-14 up to and including the 2017-18 season (n = 102373).  
Overall just under a third of pharmacy service users reported having been offered an 
appointment with their GP before attending the pharmacy (n = 31828, 30.6%).  Of these 19145 
(60.1%) reported they had been unable to attend the appointment with their GP (Table 3).  
There was a decrease in pharmacy users reporting being offered a GP appointment over time 
with a small increase in those unable to attend their appointment. Pharmacy users’ stat d 
reasons for using the pharmacy vaccination service are shown in Table 3. 
 
Impact on vaccination rates 
 
Data regarding whether or not each service user had been vaccinated in the previous flu season 
were available from 2013-14 (n = 102373).  The proportion of service users reporting not 
having been vaccinated in the previous season declined after 2013-14. An increase in the 
proportion of service users returning to CPs, having been vaccinated there previously, meant 
the proportion of service users reporting having been vaccinated by their GP in the previous 
season, declined in each year of the service (Table 2).   
 
There was a shift in balance between vaccinations administered by GPs and CPs over the study 
period in which CPs increased their share of all vaccinations in the seasonal flu programme 
from 0.3% in 2012-13 to 5.7% in 2017-18.  Despite a d crease in the proportion of vaccinations 
administered by GPs, the number of GP vaccinations increased by 48,334 (8.8%) by the end 
of the study period, albeit with a reduction between the 2014-15 and 2015-16 seasons (Table 
1). A strong positive correlation was observed between increasing CP vaccinations and total 
vaccination numbers (R=0.9316, p<0.01).   
 
 
DISCUSSION 
 
Main finding of this study 
 
A total of 103941 flu vaccinations were administered in CPs in Wales, between September 
2012 and April 2018; an over 20-fold increase in CP vaccinations was observed from 1568 in 
the 2012-13 to 36225 in the 2017-18 season with the smallest annual increase observed at 35% 
(between 2016-17 and 2017-18).   
 
Despite apparent rapid growth in the number of vaccinations they administered, CPs made only 
a small contribution to overall vaccination numbers, providing at its highest, just 5.7% of all 
flu vaccinations in any flu season. Whilst CPs have made an increasing contribution to 
vaccination numbers and increased their market share over time, this has not resulted in a 
reduction in vaccinations provided by GPs.  The decrease in vaccination numbers between 
2014-15 and 2015-16 was consistent with the decrease observed in other parts of the UK, 
including those without a CP flu service4 suggesting this was unrelated to the involvement of 
CPs.  GP vaccination numbers increased over the study period. Despite concerns12,13 that GPs, 
in the face of increased competition from CPs, would reduce orders for vaccines, leading to 
interruption to supply for some patients the data shows GPs are administering more vaccines 
than ever before. Whilst it was not possible to obtain reliable data in relation to wasted 
vaccines, the data suggests that, if GPs have reduced orders, waste must have reduced as a 
consequence. Conversely, if waste has remained the same or increased it is because, contrary 
to concerns, GPs are placing larger orders regardless of increased competition from CPs.  
 
There was no difference in overall rates of vaccination over the study period, increasing 
pharmacy numbers did not increase overall vaccine coverage, contrary to the stated objectives 
of the service.18   However, our data suggest that by the 2017-18 season, in addition to the 48334 
extra vaccinations they provided relative to 2012-13 (an increase of 8.8%), GPs would have 
had to administer a further 36238 vaccinations (a further 6.6%) simply to maintain vaccination 
rates.  Given the current concerns regarding workload pressures in general practice,19 it is at 
least feasible that GPs would have been unable to absorb the vaccinations undertaken by CPs 
and numbers and vaccination rates in Wales could have fallen. 
 
We found pharmacies administer the majority of vaccines early in the flu season, in line with 
recommendations by the Centers for Disease Control and Prevention in the United States.5  Our 
data indicate the majority of patients accessing the service were aged 65 or over, confirming 
findings of previous studies.15,16,20  This increased year on year which might be expected given 
the demographics of the population who are eligible for vaccination, with those aged 65 or over 
outnumbering those under 65 and ‘at risk’ by a factor of 1.73.8  Importantly we found CPs were 
more likely than GPs to vaccinate those under 65 and ‘ t risk’, a group in which flu vaccination 
rates are generally lower.15 This is also the group identified as the primary focus for the CP 
service.18  We found that people’s preference for using a pharmacy was mainly due to not 
needing to book an appointment; which has been previously highlighted.20 
 
We also found over 18,000 vaccinations were administered by CPs to individuals not 
vaccinated in the previous season.  However, data support concerns that CPs would ‘poach’,21  
individuals previously vaccinated at their GP surgery, confirming a large proportion of those 
vaccinated by CPs attended their GP surgery in the previous season. That said, the proportion 
moving from GP to CP vaccination decreased in each year of the service with the proportion 
of individuals vaccinated in CPs reporting returning to the CP for vaccination, increasing.  
Whilst the anonymized nature of our data does not allow us to confirm this definitively, the 
data imply there is a growing cohort of individuals who now routinely use CPs, rather than 
their GP, for their annual flu vaccination.   
 
Previous studies have demonstrated a range of factors influence take up of flu vaccination and 
not simply the wider availability of vaccinations.22  Our findings suggest whilst not 
contributing to an overall increase in vaccination rates, CP provision does contribute to an 
increase in capacity, an increase in vaccination numbers; and may help offset potential 
reductions in vaccination coverage. 
 
What is already known on this topic 
 
To our knowledge this is the first study to longitudinally investigate a CP flu vaccination 
programme. Private vaccination has been in place for some time both in the UK and other 
countries, with mixed findings on impact.14 An evaluation of the NHS England pilot 
programme found reduced vaccination uptake was documented in relation to the introduction 
of a CP immunisation programme17 while Isenor et al. found increased uptake when 
pharmacists were included in any area of an immunisation service (education, administration 
or facilitation).23  
 
What this study adds 
 
This first longtitudinal evaluation of CP flu-vaccination gives a unique insight into the 
development of the CP flu programme since its introduction in 2012. The large sample included 
data of over six full flu seasons covering every CP provided NHS flu vaccination; this enabled 
longitudinal interpretation of results over time. The increasing uptake through CPs is in line 
with a year on year increase in the overall total number of people receiving a flu vaccination. 
Despite the increase in overall numbers, immunisation targets 24 are still not being met.8 
 
Studies in the United States25 and China26 have shown the highest uptake of flu vaccination to 
be amongst those aged 65 or over, however, an evaluation of the 2013-14 CP flu programme 
in Wales found that the CP reached the ‘at-risk’ under 65 population with their uptake being 
greater than in the vaccination programme as a whole.15 Our findings confirm this effect is 
sustained over the longer term which highlights the valuable role that CP may have in providing 
equitable access to the population as a whole.  
 
Chronic respiratory disease, diabetes and carers were the main ‘at risk’ groups accessing CP 
flu vaccination. Around 17% of deaths each year from flu, are amongst those with chronic 
respiratory diseases.27 The reason for high uptake in group using CPs has been attributed to the 
numerous visits they make to the pharmacy.28 Whilst diabetes was one of the highest groups, 
it only accounted for 7.6% of CP vaccinations, despite being the highest eligibility category 
across all Flu vaccinations in Wales.8  
 
This study has shown that obtaining flu vaccination from a CP is an increasingly popular choice 
amongst patients. The findings that the proportion of patients returning to a CP for vaccination 
is increasing and that thousands of previously unvaccinated patients continue to present at CPs 
each season supports the view that CP vaccination services are acceptable and meet service 
user needs.16,29 
 
Our findings suggest patients are making an active decision to attend their CP based on a range 
of factors, the main one being not needing to book an appointment, in line with other 
research.20,30  Moreover, accessibility of CPs was an important determinant of CP vaccination 
particularly for those whose CP was located close to their homes.  This is consistent with 
previous studies.16,17,20 
Limitations 
 
The main limitation of this study is the use of secondary data. This means there was no control 
by the researchers over the data entry and choice of variables. As such, it is not possible to 
check the accuracy of data entry or investigate the reasons behind any anomalies. Nevertheless, 
the data included information on all CP NHS vaccinations which have been provided in Wales 
and is to our knowledge the most comprehensive source of information related to CP flu 
services. Occasional errors in data entry would be unlikely to have a large impact on a dataset 
of this size.  
 
CONCLUSIONS 
 
This study reaffirms a view that Wales’ CP flu service consistently engages with a statistically 
significant proportion of under vaccinated groups (those under 65 and ‘at risk’) more 
effectively than the GP programme in Wales, without reducing the number of GP vaccinations. 
Since its introduction in 2012, year on year increases in CP flu vaccination have been observed.  
There is clear indication that CPs provide convenient access to flu vaccination for many ‘at 
risk’ individuals with increasing numbers of patients choosing to visit and revisit the CP in 
preference to the GP. Importantly this shift does not reduce GP vaccination numbers which 
have grown over the study period driven both by policy changes to offer vaccination to 
additional ‘at-risk’ groups and by increasing numbers of individuals in existing eligible 
cohorts.  CP vaccination is associated with increasing vaccination numbers although not 
vaccination rates. We believe this support a view that CP-led immunisation programmes are of 
value albeit for different reasons to those initially envisaged.31 There is opportunity for greater 
collaboration between GPs and CPs to increase overall uptake. Our results reinforce the 
valuable public health role of pharmacists at the heart of their communities. 
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Figure 1:  Patient reported data available from CPflu vaccination records 
 
 
 
Figure 2. Cumulative number (percentage of seasonal total) NHS Flu vaccinations 
administered in CPs in Wales (September 2012-April 2018) n=103941) 
 
 
 
 
 
 
 
Table 1:  Flu vaccinations and uptake by flu season 2009-10 to 2017-18  
  2009-10 2010-11 2011-12 2012-13 2013-14 2014-15 2015-16 2016-17 2017-18 
  
 
Total 
 
Total since 2012-13 
Under 65 and at risk          
  
  Total vaccinations 122803 150790 160915 160915 163377 175871 171162 174997 184055 1464885 1030377 
 Pharmacy vaccinations    1098 3778 5078 8328 11084 14536 
 
43902 
 
  GP vaccinations 122803 150790 160915 159796 159443 170507 162834 163890 169532 1420510 986002 
 Pharmacy as % of total 0 0 0 0.68 2.31 2.89 4.87 6.33 7.90 
  
  Vaccine uptake % 49.1 48.5 50 50 51.1 49.3 46.9 46.9 48.5 
  
65 and over          
  
  Total vaccinations 322593 369480 392051 392051 401456 425552 423110 431791 451902 3609986 2525862 
 Pharmacy vaccinations    470 4083 6521 11458 15805 21702 
 
60039 
 
  GP vaccinations 322593 369480 392051 391602 397529 419317 411652 416009 430200 3550433 2466309 
 Pharmacy as % of total 0 0 0 0.12 1.02 1.53 2.71 3.66 4.80 
  
  Vaccine uptake % 63.5 65.7 67.1 67.8 68.3 68 66.6 66.7 68.8 
  
All vaccinations          
  
  Total vaccinations 445396 520270 552966 552966 564833 601423 594272 606788 635957 5074871 3556239 
 Pharmacy vaccinations    1568 7861 11599 19786 26889 36238 
 
103941 
 
  GP vaccinations 445396 520270 552966 551398 556972 589824 574486 579899 599732 4970943 3452311 
 Pharmacy as % of total 0 0 0 0.28 1.39 1.93 3.33 4.43 5.70 
  
  Vaccine uptake % 57.2 59.6 61.4 61.7 62.2 61.2 59.4 59.4 61.4 
  
 
 
 
 
 
 
 
Table 2: Selected characteristics of individuals receiving flu vaccination at a CP by season and overall  
 
 2012-13 2013-14 2014-15 2015-16 2016-17 2017-18 Overall 
Gender (n =103,846)        
  Female (%) 876 (55.9)  4533 (57.7) 6727 (58.1) 11325 (57.3) 15471 (57.6) 20869 (57.6) 59801 (57.6) 
 Male (%) 691 (44.1) 3321 (42.3)  4860 (41.9) 8432 (42.7) 11399 (42.4) 15342 (42.4) 44045 (42.4) 
Median Age (IQR) (n=103,880)        
    55 (40-66)  65 (50-72) 66 (52-73) 66 (53-73) 67 (55-74) 67 (55-74) 68 (54 -74) 
Age group (n = 103,941)        
  Under 65 and at risk (%) 1098 (70.0) 3778 (48.0) 5078 (43.7) 8328 (42.1) 11084 (41.2) 14536 (40.1) 43902 (42.2) 
 65 and over (%)  470  (30.0) 4083 (52.0) 6521 (56.3) 11458 (57.9) 15805 (58.8) 21702 (59.9) 60039 (57.8) 
Main at risk groups (n = 43,902)        
  Chronic Respiratory Disease (%) 498  (31.8) 1562 (19.9) 2139 (18.4) 3337 (16.9) 4585 (17.1) 5888 (16.2) 18009 (17.3) 
 Diabetes (%) 210 (13.4) 639 (8.1) 893 (7.7) 1520 (7.7) 2073 (7.7) 2501 (6.9) 7836 (7.5) 
  Carer (%)  106 (6.8) 571 (7.3) 728 (6.3) 1177 (5.9) 1316 (4.9) 1856 (5.1) 5754 (5.5) 
 Chronic Heart Disease (%) 86 (5.5) 280 (3.6) 369 (3.2) 619 (3.1) 894 (3.3) 1219 (3.4) 3467 (3.3) 
  Immuno-suppressed (%) 58 (3.7) 174 (2.2) 265 (2.3) 471 (2.4) 635 (2.4) 870 (2.4) 2473 (2.4) 
 All other (%) 140 (8.9) 552 (7.0) 684 (5.9) 1204 (6.1) 1581 (5.9) 2202 (6.1) 6363 (6.1) 
Referral (n = 103,941)        
  Self (%) 1341 (85.5)  7367 (93.7) 11186 (96.4) 18805 (95.0) 25947 (96.5) 34977 (96.5) 99623 (95.8) 
 GP (%) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 309 (1.2) 662 (1.8) 971 (0.9) 
  Other (%) 227 (14.5) 494 (6.3) 413 (3.6) 981 (5.0) 633 (2.3) 599 (1.7) 3347 (3.3) 
Vaccination in previous flu season (n = 102,373)        
  Not vaccinated (%) - 1960 (24.9) 1990 (17.2) 3366 (17.0) 4132 (15.4) 7096 (19.6) 18544 (18.1) 
 GP Practice (%) - 5035 (64.1) 6191 (53.4) 10643 (53.8) 12711 (47.3) 14884 (41.1) 49464 (48.3) 
  CP - NHS (%) - 485 (6.2) 2941 (25.4) 4968 (25.1) 9096 (33.8) 13081 (36.1) 30571 (29.9) 
 CP - paid for (%) - 225 (2.9) 244 (2.1) 378 (1.9) 406 (1.5) 437 (1.2) 1690 (1.7) 
  Other (%) - 156 (2.0) 233 (2.0) 431 (2.2) 544 (2.0) 740 (2.0) 536 (2.1) 
 
 
 
 
 
 
 
Table 3: Factors influencing decision to attend CP for flu vaccination 
 2013-14 2014-15 2015-16 2016-17 2017-18 Overall 
Offered GP appointment (n = 102,373)       
  Yes (%) 3555 (45.2) 4249 (36.6) 6901 (34.9) 9635 (35.8) 7488 (20.7) 31828 (30.6) 
 No (%) 4306 (54.8) 7350 (63.4) 12885 (65.1) 17254 (64.2) 28750 (79.3) 70545 (69.4) 
Unable to attend GP appointment (n = 31,828)       
  Yes (%) 2138 (60.1) 2409 (56.7) 4071 (59.0) 5767 (59.9) 4760 (63.6) 19145 (60.2) 
 No (%) 1417 (39.9) 1840 (43.3) 2830 (41.0) 3868 (40.1) 2728 (36.4) 12683 (39.8) 
        
  Did not need an appointment 4593 (58.4) 5631 (48.5) 9417 (47.6) 10787 (41.2) 16373 (40.1) 46801 (42.2) 
 Pharmacy is near home 1793 (22.8) 2524 (21.8) 4638 (23.4) 7267 (27.0) 8608 (23.8) 24830 (24.3) 
  Visiting pharmacy for another reason 2133 (27.1) 2838 (24.5) 5423 (27.4) 6482 (24.1) 6526 (18.0) 23402 (22.9) 
 Pharmacy is near place of work 465 (5.9) 687 (5.9) 1053 (5.3) 1164 (4.3) 1634 (4.5) 5003 (4.9) 
  Other reason (not stated) 1085 (13.8) 1830 (15.8) 2885 (14.6) 2900 (10.8) 3651 (10.1) 12351  (12.1) 
  Open at time when could not get appointment - - - 2621 (9.8) 3256 (9.0) 5877 (9.3) 
 
 
